The Cool Down on MSN31m
Company behind $1.3 billion plant makes stunning decision to halt construction: 'The wrong project, at the wrong place and time'
The many manufacturing and industrial plants along the Mississippi River are a major environmental justice issue. Company ...
Bain Capital Nears Acquisition Of Mitsubishi's Pharma Division In $3.2 Billion Deal
Dubai Bain Capital is in the final stages of negotiations to acquire Mitsubishi Chemical Group's pharmaceutical subs ...
Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn
Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
Channel NewsAsia Singapore15h
Mitsubishi Chemical to sell drug unit to Bain in $3.36 billion deal
Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity ...
Bain Capital buys Japanese pharma for $3.3B
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
alternativeswatch18h
Bain Capital to acquire Japanese pharma giant in $3.3bn deal
Bain Capital entered a deal to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) from Mitsubishi Chemical Group for 510 ...
BioPharma Dive19h
Bain buys Mitsubishi pharma unit; Bausch + Lomb deal talks come up empty
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...
Bain Capital to buy Mitsubishi Chemical’s pharma unit for $3.3B
Investment firm Bain Capital said on Friday that it has signed an agreement to acquire Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group (OTCPK:MTLHY) for approximately 510 billion JPY (3.3 ...
PE Hub22h
Bain Capital to acquire Tanabe Pharma in a carveout from Mitsubishi Chemical Group
Bain Capital has agreed to acquire Tanabe Pharma, the pharma arm of Mitsubishi Chemical Group Corporation. The deal puts Tanabe Pharma at a valuation of about $3.3 billion. Founded in 1678, Tanabe ...